| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |